Prognostic value of measurable residual disease monitoring by next ...
NGS-MRD assay shows prognostic value in AML patients post-allo-HSCT, with persistent mutations at pre-HSCT and post-HSCT-1m linked to higher relapse and mortality risks. Conditioning intensity affects NGS-MRD's prognostic impact, suggesting serial monitoring post-HSCT for better outcomes.
Reference News
Prognostic value of measurable residual disease monitoring by next ...
NGS-MRD assay shows prognostic value in AML patients post-allo-HSCT, with persistent mutations at pre-HSCT and post-HSCT-1m linked to higher relapse and mortality risks. Conditioning intensity affects NGS-MRD's prognostic impact, suggesting serial monitoring post-HSCT for better outcomes.